Elevance Health (ELV) Long-Term Investments (2009 - 2026)

Elevance Health (ELV) has 18 years of Long-Term Investments data on file, last reported at $11.0 billion in Q1 2026.

• Long-Term Investments for Q1 2026 came in at $11.0 billion, up 8.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.0 billion (up 8.28% YoY), and the FY2025 annual result was $10.8 billion, up 947.25% from the prior year.
• Long-Term Investments climbed to $11.0 billion in Q1 2026 per ELV's latest filing, from $10.8 billion in the prior quarter.
• Over five years, Long-Term Investments peaked at $11.0 billion in Q1 2026 and troughed at $467.0 million in Q2 2022.
• A 5-year average of $3.7 billion and a median of $1.0 billion in 2024 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2023 and 2025: Long-Term Investments soared 1043.55% in 2023, then plunged 88.17% in 2025.
• A 5-year view of Long-Term Investments shows it stood at $581.0 million in 2022, then soared by 50.77% to $876.0 million in 2023, then increased by 18.15% to $1.0 billion in 2024, then jumped by 947.25% to $10.8 billion in 2025, then gained by 1.57% to $11.0 billion in 2026.
• Business Quant data shows ELV's Long-Term Investments at $11.0 billion in Q1 2026, $10.8 billion in Q4 2025, and $1.1 billion in Q3 2025.